|
Microchiping Citizens Included in Healthcare Bill
Microchiping Citizens Included in Healthcare Bill
Buried deep within the over 1,000 pages of the massive US Health Care Bill (PDF) in a “non-discussed” section titled: Subtitle C-11 Sec. 2521— National Medical Device Registry, and which states the following:
‘‘The Secretary shall establish a national medical device registry (in this subsection referred to as the ‘registry’) to facilitate analysis of postmarket safety and outcomes data on each device that — ‘‘(A) is or has been used in or on a patient; and ‘‘(B) is — ‘‘(i) a class III device; or ‘‘(ii) a class II device that is implantable, life-supporting, or life-sustaining. ‘‘(2) In developing the registry, the Secretary shall, in consultation with the Commissioner of Food and Drugs, the Administrator of the Centers for Medicare & Medicaid Services, the head of the Office of the National Coordinator for Health Information Technology, and the Secretary of Veterans Affairs, determine the best methods for —‘‘(A) including in the registry, in a manner consistent with subsection (f), appropriate information to identify each device described in paragraph (1) by type, model, and serial number or other unique identifier; ‘‘(B) validating methods for analyzing patient safety and outcomes data from multiple sources and for linking such data with the information included in the registry as described in subparagraph (A), including, to the extent feasible, use of — ‘‘(i) data provided to the Secretary under other provisions of this chapter; and ‘‘(ii) information from public and private sources identified under paragraph (3); ‘‘(C) integrating the activities described in this subsection with — ‘‘(i) activities under paragraph (3) of section 505(k) (relating to active postmarket risk identification); ‘‘(ii) activities under paragraph (4) of section 505(k) (relating to advanced analysis of drug safety data); and ‘‘(iii) other postmarket device surveillance activities of the Secretary authorized by this chapter; and ‘‘(D) providing public access to the data and analysis collected or developed through the registry in a manner and form that protects patient privacy and proprietary information and is comprehensive, useful, and not misleading to patients, physicians, and scientists. ‘‘(3)(A) To facilitate analyses of postmarket safety and patient outcomes for devices described in paragraph (1), the Secretary shall, in collaboration with public, academic, and private entities, develop methods to— ‘‘(i) obtain access to disparate sources of patient safety and outcomes data, including — ‘‘(I) Federal health-related electronic data (such as data from the Medicare program under title XVIII of the Social Security Act or from the health systems of the Department of Veterans Affairs); ‘‘(II) private sector health-related electronic data (such as pharmaceutical purchase data and health insurance claims data); and ‘‘(III) other data as the Secretary deems necessary to permit postmarket assessment of device safety and effectiveness; and ‘‘(ii) link data obtained under clause (i) with information in the registry.
In “real world speak”, according to this report, this new law, when fully implemented, provides the framework for making the United States the first Nation in the World to require each and every one of its citizens to have implanted in them a radio-frequency identification (RFID) microchip for the purpose of controlling who is, or isn’t, allowed medical care in their country.
http://waysandmeans.house.gov/media...HCA09001xml.pdf
http://industry.bnet.com/pharma/100...t-score-empire/
|
